Clinical Report: Serum Metabolite Levels at Baseline as Predictors of Fracture Risk
Overview
This study identifies specific serum metabolites at baseline that are associated with fracture risk in Black individuals with Type 2 Diabetes Mellitus (T2D). Higher levels of 7,8-dihydrofolate and reduced metabolites related to the tricarboxylic acid cycle were associated with increased fracture risk.
Background
Type 2 Diabetes Mellitus (T2D) is a prevalent metabolic disorder that increases fracture risk, particularly in specific populations such as Black individuals. Understanding the metabolic changes associated with T2D is important for identifying mechanisms contributing to skeletal fragility and fracture risk in these populations. This study focuses on the relationship between serum metabolite levels and fracture risk in Black patients with T2D.
Data Highlights
Metabolite
Association with Fracture Risk
Significance
7,8-dihydrofolate
Higher levels in fractured participants
Significant (adjusted and unadjusted p-values)
Tricarboxylic acid cycle metabolites
Reduced levels in fractured participants
Significant (unadjusted p-values)
Key Findings
Higher baseline levels of 7,8-dihydrofolate were found in participants who later fractured.
Several metabolites related to the tricarboxylic acid cycle were significantly reduced in those who fractured.
The study analyzed 465 targeted metabolites in serum from 571 participants with T2D.
Participants were randomized to intensive or standard glycemia strategies, which did not affect fracture risk.
Clinical Implications
The identification of specific serum metabolites associated with fracture risk provides insights into metabolic differences in Black patients with T2D.
Conclusion
Altered systemic metabolism in Black individuals with T2D is associated with fracture risk. Further research is needed to validate these metabolites as predictors of fracture.
